These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 8099489)
1. Clinical and epidemiological implications of the Centers for Disease Control/World Health Organization reclassification of AIDS cases. Brettle RP; Gore SM; Bird AG; McNeil AJ AIDS; 1993 Apr; 7(4):531-9. PubMed ID: 8099489 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of three clinical case definitions for advanced HIV disease. Gallant JE; Somani J; Chaisson RE; Stanton D; Smith M; Quinn TC AIDS; 1992 Mar; 6(3):295-9. PubMed ID: 1348946 [TBL] [Abstract][Full Text] [Related]
3. Use of monitored CD4 cell counts: predictions of the AIDS epidemic in Scotland: CD4 Collaborative Group. AIDS; 1992 Feb; 6(2):213-22. PubMed ID: 1348418 [TBL] [Abstract][Full Text] [Related]
4. CD4 surveillance in Scotland: perspectives on severe HIV-related immunodeficiency. CD4 Collaborative Group. AIDS; 1997 Oct; 11(12):1509-17. PubMed ID: 9342074 [TBL] [Abstract][Full Text] [Related]
5. Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting. Chaisson RE; Stanton DL; Gallant JE; Rucker S; Bartlett JG; Moore RD AIDS; 1993 Jun; 7(6):857-62. PubMed ID: 8103343 [TBL] [Abstract][Full Text] [Related]
6. Differential survival of patients with AIDS according to the 1987 and 1993 CDC case definitions. Vella S; Chiesi A; Volpi A; Giuliano M; Floridia M; Dally LG; Binkin N JAMA; 1994 Apr; 271(15):1197-9. PubMed ID: 7908705 [TBL] [Abstract][Full Text] [Related]
7. Predictors of mortality among HIV-infected women in Kigali, Rwanda. Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389 [TBL] [Abstract][Full Text] [Related]
8. Effect of the revised CDC case definition of AIDS on the number of AIDS cases in the Sydney AIDS Prospective Study. Tindall B; Sharkey T; Kaldor J; Cooper DA Aust N Z J Med; 1992 Aug; 22(4):369-73. PubMed ID: 1359862 [TBL] [Abstract][Full Text] [Related]
9. From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA; 1993 Feb; 269(6):729-30. PubMed ID: 8093740 [TBL] [Abstract][Full Text] [Related]
10. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep; 1992 Dec; 41(RR-17):1-19. PubMed ID: 1361652 [TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand. Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412 [TBL] [Abstract][Full Text] [Related]
12. AIDS in Edinburgh drug users: observations on the epidemic and implications for its future management. Flegg PJ; Brettle RP J Infect; 1991 Mar; 22(2):113-8. PubMed ID: 1673989 [TBL] [Abstract][Full Text] [Related]
13. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I. AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100 [TBL] [Abstract][Full Text] [Related]
14. Laboratory markers and the risk of developing HIV-1 disease among injecting drug users. Alcabes P; Selwyn PA; Davenny K; Hartel D; Buono D; Schoenbaum EE; Klein RS; Friedland GH AIDS; 1994 Jan; 8(1):107-15. PubMed ID: 7912083 [TBL] [Abstract][Full Text] [Related]
15. Continued drug use and other cofactors for progression to AIDS among injecting drug users. Ronald PJ; Robertson JR; Elton RA AIDS; 1994 Mar; 8(3):339-43. PubMed ID: 7913328 [TBL] [Abstract][Full Text] [Related]
16. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. Farizo KM; Buehler JW; Chamberland ME; Whyte BM; Froelicher ES; Hopkins SG; Reed CM; Mokotoff ED; Cohn DL; Troxler S JAMA; 1992 Apr; 267(13):1798-805. PubMed ID: 1347573 [TBL] [Abstract][Full Text] [Related]
17. Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group. Aledort LM; Hilgartner MW; Pike MC; Gjerset GF; Koerper MA; Lian EY; Lusher JM; Mosley JW BMJ; 1992 Jan; 304(6821):212-6. PubMed ID: 1346752 [TBL] [Abstract][Full Text] [Related]
18. Implications of the revised surveillance definition: AIDS among New York City drug users. Des Jarlais DC; Wenston J; Friedman SR; Sotheran JL; Maslansky R; Marmor M; Yancovitz S; Beatrice S Am J Public Health; 1992 Nov; 82(11):1531-3. PubMed ID: 1359800 [TBL] [Abstract][Full Text] [Related]
19. Pre-AIDS mortality in the Edinburgh City Hospital HIV cohort. Seaman SR; Brettle RP; Gore SM Stat Med; 1997 Nov; 16(21):2459-74. PubMed ID: 9364654 [TBL] [Abstract][Full Text] [Related]
20. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic. Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]